The MultimorbiditY COllaborative Medication Review And DEcision Making (MyComrade) study: a protocol for a cross-border pilot cluster randomised controlled trial.
Creators: name: Hynes, Lisa
name: Murphy, Andrew W
name: Hart, Nigel
name: Kirwan, Collette
name: Mulligan, Sarah
name: Leathem, Claire
name: McQuillan, Laura
name: Maxwell, Marina
name: Carr, Emma
name: Walkin, Scott
name: McCarthy, Caroline
name: Bradley, Colin
name: Byrne, Molly
name: Smith, Susan M
name: Hughes, Carmel
name: Corry, Maura
name: Kearney, Patricia M
name: McCarthy, Geraldine
name: Cupples, Margaret
name: Gillespie, Paddy
name: Newell, John
name: Glynn, Liam
name: Alvarez-Iglesias, Alberto
name: Sinnott, Carol
Publisher: name: Apollo - University of Cambridge Repository
Year: 2022
Subjects: Study Protocol
Feasibility study
Behavioural intervention
Primary care
Behaviour change
Multimorbidity
Medication review
Behaviour change wheel
Cluster randomised controlled trial

description: BACKGROUND: While international guidelines recommend medication reviews as part of the management of multimorbidity, evidence on how to implement reviews in practice in primary care is lacking. The MultimorbiditY Collaborative Medication Review And Decision Making (MyComrade) intervention is an evidence-based, theoretically informed novel intervention which aims to support the conduct of medication reviews for patients with multimorbidity in primary care. Our aim in this pilot study is to evaluate the feasibility of a trial of the intervention with unique modifications accounting for contextual variations in two neighbouring health systems (Republic of Ireland (ROI) and Northern Ireland (NI)). METHODS: A pilot cluster randomised controlled trial will be conducted, using a mixed-methods process evaluation to investigate the feasibility of a trial of the MyComrade intervention based on pre-defined progression criteria. A total of 16 practices will be recruited (eight in ROI; eight in NI), and four practices in each jurisdiction will be randomly allocated to intervention or control. Twenty people living with multimorbidity and prescribed ≥ 10 repeat medications will be recruited from each practice prior to practice randomisation. In intervention practices, the MyComrade intervention will be delivered by pairs of general practitioners (GPs) in ROI, and a GP and practice-based pharmacist (PBP) in NI. The GPs/GP and PBP will schedule the time to review the medications together using a checklist. Usual care will proceed in practices in the control arm. Data will be collected via electronic health records and postal questionnaires at recruitment and 4 and 8 months after randomisation. Qualitative interviews to assess the feasibility and acceptability of the intervention and explore experiences related to multimorbidity management will be conducted with a purposive sample of GPs, PBPs, practice administration staff and patients in intervention and control practices. The feasibility of conducting a health economic evaluation as part of a future definitive trial will be assessed. DISCUSSION: The findings of this pilot study will assess the feasibility of a trial of the MyComrade intervention in two different health systems. Evaluation of the progression criteria will guide the decision to progress to a definitive trial and inform trial design. The findings will also contribute to the growing evidence-base related to intervention development and feasibility studies. TRIAL REGISTRATION: ISRCTN Registry, ISRCTN80017020 . Date of confirmation is 4/11/2019.